AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 66 filers reported holding AQUESTIVE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 16.03 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $42,000 | -19.2% | 10,500 | +5.0% | 0.00% | -33.3% |
| Q1 2021 | $52,000 | -89.6% | 10,000 | -90.3% | 0.00% | -93.8% |
| Q3 2020 | $501,000 | -24.7% | 103,240 | -24.6% | 0.05% | -23.8% |
| Q2 2020 | $665,000 | +250.0% | 136,923 | +57.8% | 0.06% | +173.9% |
| Q1 2020 | $190,000 | -47.7% | 86,766 | +39.0% | 0.02% | -28.1% |
| Q4 2019 | $363,000 | +16.0% | 62,434 | -36.6% | 0.03% | +3.2% |
| Q3 2019 | $313,000 | +5.4% | 98,489 | +39.2% | 0.03% | +3.3% |
| Q2 2019 | $297,000 | – | 70,733 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |